CORRESP Filing
BioAtla, Inc.
Date: May 12, 2025 · CIK: 0001826892 · Accession: 0001193125-25-117883
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287011
Letter
Re:
11085 Torreyana Road San Diego, CA 92121 May 12, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Tim Buchmiller, Office of Life Sciences
BioAtla, Inc. Registration Statement on Form S-3 Filed May 6, 2025 File No. 333-287011 REQUEST FOR ACCELERATION OF EFFECTIVENESS Acceleration Request
Requested Date:
May 14, 2025
Requested Time:
4:00 p.m. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BioAtla, Inc. (the “ Company ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) take appropriate action to declare the Company’s Registration Statement on Form S - 3 (File No. 333-287011) effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable. The Company hereby authorizes Niki Fang, who is an attorney with the Company’s outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration. The Company requests that it be notified of such effectiveness by a telephone call to Ms. Fang at (415) 773-5540. [Signature page follows]
Sincerely,
BIOATLA, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP 11085 Torreyana Road San Diego, CA 92121 May 12, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Tim Buchmiller, Office of Life Sciences Re: BioAtla, Inc. Registration Statement on Form S-3 Filed May 6, 2025 File No. 333-287011 REQUEST FOR ACCELERATION OF EFFECTIVENESS Acceleration Request Requested Date: May 14, 2025 Requested Time: 4:00 p.m. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BioAtla, Inc. (the “ Company ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) take appropriate action to declare the Company’s Registration Statement on Form S - 3 (File No. 333-287011) effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable. The Company hereby authorizes Niki Fang, who is an attorney with the Company’s outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration. The Company requests that it be notified of such effectiveness by a telephone call to Ms. Fang at (415) 773-5540. [Signature page follows] Sincerely, BIOATLA, INC. By: /s/ Richard Waldron Name: Richard Waldron Title: Chief Financial Officer cc: Chris Vasquez, BioAtla, Inc. Niki Fang, Esq., Orrick, Herrington & Sutcliffe LLP